APEN Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Apr 2023 @ 22:00):

Stats
Tagesvolumen	1.64M
Durchschnittsvolumen	1.33M
Marktkapitalisierung	579.72M
EPS	$0 ( 2024-03-28 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.43
ATR14	$0.0390 (0.39%)

Insider Trading

Date	Person	Action	Amount	type
2023-04-04	Mcgaughy R Kent Jr	Sell	400 675	Common Stock
2023-04-04	Mcgaughy R Kent Jr	Sell	38 667	Stock Option (Right to Buy)
2023-04-04	Cpmg Inc	Sell	400 675	Common Stock
2023-04-04	Barr John R	Sell	44 082	Common Stock
2023-04-04	Barr John R	Sell	5 271	Non-Qualified Stock Option (right to buy)

INSIDER POWER
-16.28
Last 98 transactions
Buy: 5 638 377 \| Sell: 4 907 735

Volumen Korrelation

Lang: 0.13 (neutral)

Kurz: 0.00 (neutral)

Signal:(66.037) Neutral

Apollo Endosurgery Inc Korrelation

10 Am meisten positiv korreliert
NETE	0.955
MDGL	0.952
RAVN	0.922
SRAC	0.9
UFPT	0.886
AGYS	0.883
NRIM	0.882
PODD	0.879
TSBK	0.879
AMRB	0.875

10 Am meisten negativ korreliert
BVXV	-0.948
SNPX	-0.938
SVAC	-0.935
FREQ	-0.934
PAIC	-0.933
SVOK	-0.928
TSP	-0.923
ALTM	-0.922
ZI	-0.919
SGRP	-0.917

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Apollo Endosurgery Inc Korrelation - Währung/Rohstoff

-0.24
( neutral )

0.25
( neutral )

0.08
( neutral )

-0.16
( neutral )

-0.19
( neutral )

0.32
( neutral )

Apollo Endosurgery Inc Finanzdaten

Annual	2022
Umsatz:	$76.86M
Bruttogewinn:	$42.43M (55.20 %)
EPS:	$-0.980

FY	2022
Umsatz:	$76.86M
Bruttogewinn:	$42.43M (55.20 %)
EPS:	$-0.980

FY	2021
Umsatz:	$62.99M
Bruttogewinn:	$34.96M (55.50 %)
EPS:	$-0.820

FY	2020
Umsatz:	$42.05M
Bruttogewinn:	$22.24M (52.90 %)
EPS:	$-0.990

Financial Reports:

No articles found.

Apollo Endosurgery Inc

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.